BAX
38
2
TROW
37
8
AN
49
2
HAS
29
3
IVZ
42
13
FITB
36
3
GM
55
6
JNPR
59
3
COP
36
2
GILD
55
5
MTB
38
4
UHS
50
4
DRI
74
5
V
70
14
WAT
55
11
ICE
53
5
HPQ
55
3
DE
49
3
KLAC
45
3
EBAY
42
2
BAX
38
2
TROW
37
8
AN
49
2
HAS
29
3
IVZ
42
13
FITB
36
3
GM
55
6
JNPR
59
3
COP
36
2
GILD
55
5
MTB
38
4
UHS
50
4
DRI
74
5
V
70
14
WAT
55
11
ICE
53
5
HPQ
55
3
DE
49
3
KLAC
45
3
EBAY
42
2
Financhill
Back

AnaptysBio Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
16

ANAB
AnaptysBio

Last Price:
$14.55
Seasonality Move:
-2.76%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
$0.53
Seasonality Move:
-0.66%
Sell
16
AnaptysBio (ANAB) is a Sell

Is AnaptysBio a Buy, Sell or Hold?

  • The current AnaptysBio [ANAB] share price is $14.50. The Score for ANAB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • ANAB is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.53. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ANAB Stock Price Chart

What is AnaptysBio's stock price today?

  • The AnaptysBio share price today is $14.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANAB is experiencing slight selling pressure.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.53
    The current trend is relatively stagnant and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.

ANAB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.57 Sell
Relative Strength Index (14 RSI): 30.89 Sell
Chaikin Money Flow: -703611 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.57 - 24.19) Sell
Bollinger Bands (100): (22.27 - 36.89) Sell

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 39.44 Sell
Chaikin Money Flow: 514099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.53 - 0.67) Sell
Bollinger Bands (100): (0.49 - 0.69) Sell

ANAB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.45 Sell
20-day SMA: 20.51 Sell
50-day SMA: 23.97 Sell
200-day SMA: 27.31 Sell
8-day EMA: 16.37 Sell
20-day EMA: 19.05 Sell
50-day EMA: 23.12 Sell
200-day EMA: 26.43 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.54 Sell
20-day SMA: 0.57 Sell
50-day SMA: 0.63 Sell
200-day SMA: 1.88 Sell
8-day EMA: 0.54 Sell
20-day EMA: 0.57 Sell
50-day EMA: 0.64 Sell
200-day EMA: 4.7 Sell

AnaptysBio Earnings Growth & ANAB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.28 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

AnaptysBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):